Canada's NeuPath Q2 revenue up 25%, beats estimates
Overview
NeuPath Q2 revenue rises 25% yr/yr, beating analyst expectations, per LSEG data
Adjusted EBITDA for Q2 up 69% yr/yr, reflecting operational improvements
Co cites strong demand for Arthrosamid
Outlook
NeuPath expects continued growth in the second half of 2025
Company plans further investments to enhance clinic network
NeuPath focuses on strategic opportunities for growth
Result Drivers
CAPACITY UTILIZATION - Improved capacity utilization to 84% in Q2 2025, up from 77% in Q2 2024, driven by stronger revenues and optimization of clinic space
ARTHROSAMID DEMAND - Strong early demand for Arthrosamid procedure contributed to revenue growth in Q2 2025
ONE-TIME PAYMENT - Revenue increase partly due to a one-time retroactive payment related to prior period physician reimbursements
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Beat | C$23.60 mln | C$19.40 mln (1 Analyst) |
Q2 Adjusted EBITDA |
| C$2.20 mln |
|
Analyst Coverage
The one available analyst rating on the shares is "buy"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for NeuPath Health Inc is C$0.50, about 49% above its August 13 closing price of C$0.26
Press Release: ID:nBw1HwYmTa
Related Articles
Alibaba’s Friday Earnings to Crown China Tech’s Q2 Winner
TradingKey - Names like JD.com, Pinduoduo, Tencent, and Alibaba represent the top-tier of Chinese tech stocks trading in the U.S. But their FY2025 Q2 earnings paint very different pictures.
NVIDIA Q2 FY2026: Surfing the AI Surge with Blackwell, Steering Through China’s Export Challenges
TradingKey - NVIDIA Corporation (NASDAQ: NVDA) reported strong Q2 FY2026 results on August 27, 2025, after market close, driven by robust AI-powered demand and adoption of its next-generation Blackwell GPU platform. The company delivered significant revenue and profit beats overall, with...
Nvidia Q2 Earnings Expectations: With Little Room for Error, Will China-Related Risks Be Magnified?
TradingKey - Ahead of Nvidia Q2 FY2026 earnings report, multiple Wall Street firms have raised their price targets on Nvidia, reflecting strong confidence in AI demand. While analysts continue to forecast robust ~50% year-over-year growth in revenue and EPS, the China variable remains a major risk
Eurozone Q2 GDP Commentary: Will the Euro's Upward Momentum Persist?
TradingKey - On 14 August 2025, Eurostat published Q2 GDP figures, revealing a drop in the Eurozone's quarter-on-quarter growth from 0.6% in the first quarter to 0.1%. Consequently, annual growth eased from 1.5% to 1.4%. The slowdown primarily stems from the diminishing boost from European...
Bitcoin Price Forecast: Trends and Investment Outlook from 2025 to 2030
From $0.01 in 2009 to $120,000+ in 2025, Bitcoin has evolved from obscurity to a globally recognized financial asset. While institutions and governments increasingly embrace it, investors must remain vigilant against volatility, security risks, and scams.
